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Abstract 
Introduction: In India, several science agencies are promoting Stem Cell Research (SCR). There is paucity of studies 
which document the perception of doctors about SCR, especially physicians in academia. This study was carried 
out to assess perception of physicians in academia towards Human Stem Cell Research (HSCR) and related policies 
in India. Methods: We interviewed 200 doctors from three different government medical colleges of Rajasthan. A 
semi-structured questionnaire was used to discern their awareness, attitudes towards utilization of SCR and their 
knowledge of related international and ethical policy issues. Results: Though mostly 177 (96.2%) physicians 
acknowledged the public health benefits of promoting stem cell research in India, but 166 (66.2%) were not aware 
of the stem cell research policy of the Government of India and 111 (60.3%) were not aware of the ICMR guidelines 
for Human Stem Cell Research in India. There was a strong desire among academic physicians 152 (82.6%) to 
incorporate a course on SCR to the students in the near future. Discussion: Physicians in academia have views that 
SCR should be encouraged to treat clinical diseases and this technology should be brought into India in a big way. 
They seem to believe that one of the ways to promote the benefits of SCR would be to raise awareness by 
publishing success stories in widely read Indian Medical Journals, giving updated information regarding its uses in 
clinical practices and its inclusion as a part of the curricula for health professionals. 
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Introduction  
Stem cells are primal cells common to all multi 
cellular organisms that retain the ability to renew 
themselves through cell division and can be 
differentiated into a wide range of specialized cell 
types, (1). These cells migrate to injured areas within 
the body and get transplanted and transform 
themselves into new tissue cells that replace the 
damaged ones. Stem cells have the capacity to 
multiply and renew themselves almost indefinitely 
(2). They can form nerve cells, muscle cells and blood 
cells, which cannot multiply by themselves and have 
limited life spans (3). Stem cell therapy is the use of 
stem cells to treat or prevent a disease or condition. 
Bone marrow transplant is the most widely used 
stem cell therapy, but some therapies derived from 
umbilical cord blood are also in use. Research is 
underway to develop various sources for stem cells, 
and to apply stem cell treatments for 
neurodegenerative diseases, diabetes, heart 
disease, and other conditions, (1). 
Stem cell research holds great promise for improving 
human health by restoring cellular and organ 
functions, damaged by degeneration and injuries. At 
the same time, it also raises several scientific, ethical 
and social issues in the development of such 
applications, (4). Over the past few years, human 
stem cell research (SCR) has emerged as a new and 
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exciting field in the life sciences while also being 
novel in its potential for clinical applications. 
With the ability of scientists to isolate and culture 
embryonic stem cells, and with scientists' growing 
ability to create stem cells using somatic cell nuclear 
transfer and techniques to create induced 
pluripotent stem cells, controversy has crept in, both 
related to abortion politics and to human cloning. 
Stem cell therapy is helpful to treat many blood 
disorder such as thalassemia, sickle cell anemia, 
leukemia, aplastic anemia and other organ related 
disorder such as muscular dystrophy, spinal cord 
injury, diabetes, chronic kidney disease (CKD), 
cerebral palsy, autism, optic nerve atrophy, retinitis 
pigmentosa, lung (COPD) disease and liver cirrhosis, 
(5). Additionally, efforts to market treatments based 
on transplant of stored umbilical cord blood have 
proven controversial (6). Stem cells will completely 
alter the way we practice medicine.  
In India, several science agencies of the government 
are promoting SCR, (7). However, medical 
professionals have incomplete knowledge of this. 
There are very few studies, which have documented 
the perception of doctors specially physicians in 
academia. Main role of doctors in academics is to 
train and mentor resident medical students and new 
doctors. They also translate latest research in the 
field of medical biology for clinical use. 
Aims & Objectives  
To assess the knowledge and perception of such 
physicians towards human Stem Cell Research 
(HSCR) and policy in India. 
Material and Methods  
We interviewed 200 doctors in academic positions of 
various grades from three different government 
medical colleges of Rajasthan in 2014. A pre tested 
semi-structured questionnaire was used after 
getting approval of the Institutional Ethical 
committee to discern their awareness, attitudes 
towards utilization of SCR and their knowledge of 
related international and ethical policy issues. 
Results 
The respondents were mostly male (71%), less than 
45 years of age (63%) and were specialists (66%) in 
clinical and non-clinical branches (Table 1). 
Though mostly 177 (96.2%) physicians 
acknowledged the public health benefits of 
promoting Stem Cell Research in India, but 166 ( 
66.2%) were not aware of the stem cell research 
policy of the Government of India and 111 ( 60.3%) 
were not aware of the ICMR guidelines for Human 
Stem Cell Research in India. 
More than 80% of the participants felt that stem cell 
use should be included in the current undergraduate 
curriculum and that Indian doctors are totally 
competent in using this technology for clinical 
conditions (Figure1). However, only 45% of the 
respondents felt that harvesting a fertilized egg for 
human cloning is ethical. Less than 60% of the 
doctors were of the opinion that human cloning is 
dangerous.  
When asked about what practices in HSCR are 
unethical only 47% responded that harvesting from 
human embryo is unethical, 57% felt human cloning 
and 65% felt stem cells from abortus is unethical 
(Figure 2).There was a strong desire among academic 
physicians 152 (82.6%) to teach a course on Stem Cell 
research to the students in the near future and 
majority of them 150 (81.5%) felt that it is worth 
spending public funds on Stem Cell research in India. 
Among the health professionals interviewed 77% 
knew of the role of stem cell therapy in non-
communicable diseases like diabetes and 72% in 
cardiac failure but only 55% and 30% were aware of 
the role of this technology in HIV and Kala Azar 
respectively (Figure 3). Also, 189 (96%) of them felt 
the need to develop a training program for students 
and scientists who would contribute to the 
manpower required for this field in the country. 
Discussion  
It was found that many physicians in academia have 
views that stem cell research should be encouraged 
to treat clinical diseases and this technology should 
be brought to India in a big way. The utilization of 
treatments was found more in favour of chronic 
ailments than infectious disease. It was felt that the 
scientific faculty involved in basic research on 
utilization of HSCR in treatments will have 
translational potential, mostly with adult stem cells 
at present. 
In fact, India is formulating plans for a national stem 
cell initiative to boost clinical applications of stem 
cell research, develop linkages between publicly and 
privately-funded research groups, enable sharing of 
facilities, ideas, and research and business 
opportunities, promote interactions between 
researchers and clinicians and prioritize areas for 
research funding. The proposal, being drafted by the 
Indian Council of Medical Research and the 
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Department of Biotechnology, includes creating a 
fund to boost stem cell research.  
More than 15 labs in the country are engaged in stem 
cell research, (8), focusing mostly on clinical 
applications of stem cells in ophthalmology, 
cardiology and spinal cord repair. Indian researchers 
have pioneered a stem cell injection for reviving 
heart muscles (9) and are now planning to use stem 
cells derived from bone marrow to treat chronic liver 
failure and to regenerate tissue to treat heart 
disease, traumatic brain injury and Crohn's disease. 
Indian doctors have also successfully treated 
blindness using stem cells derived from the eye. In 
Lifeline Hospitals, Chennai, they are offering Adult 
Stem cell therapy for Spinal Injuries, advanced heart 
disease, liver cirrhosis and cancer, (10). Life Cell, a 
service provided by Asia Cryo-Cell Pvt Ltd, pioneers 
in cord blood stem cell banking in India, and Sri 
Ramachandra Medical College and Research 
Institute (SRMC & RI), a deemed University and an 
autonomous body, announced in Chennai their joint 
venture to set up India’s first exclusive stem cell 
transplant centre, (11). 
There was an expressed need for more clarity in 
ethics and policy issues of stem cell use and that it is 
time that these should be revised The two major 
funding agencies of Government of India e.g. 
Department of Biotechnology (DBT) and Indian 
Council of Medical Research (ICMR), have jointly 
formulated the "Guidelines for Stem Cell Research 
and Therapy" in 2012, which requires updation and 
revision. Based on the review of the current world 
scenario of Cell Based Therapy CBT research and 
development, suggestions have been made for the 
development of a new CBT policy that will help in 
progress of research and patient treatment in India. 
Additionally, stem cell tourism in Russia and India 
has raised several scientific/medical, ethical, and 
policy issues by the provision of unproven stem cell-
based treatments within these countries, (12). 
Hence, in order to establish a clear distinction 
between treatments based on proven clinical 
research and "innovative treatment”, regulatory 
measures need to be developed and or strengthened 
in accordance with internationally accepted 
standards in such countries to protect those seeking 
stem cell treatments. 
Conclusion 
The medical fraternity seems to believe that one of 
the ways to promote the benefits of stem cell 
research would be to raise awareness by publishing 
the success stories in Indian journals, giving 
information regarding its uses in clinical practices. 
There is a consensus among health professionals 
that it should be part of the curricula for medical, 
dental and paramedical graduates, as health 
professionals in their academic career are 
responsible for developing and evaluating training 
programs, designing curricula and assessing resident 
doctors, researching and implementing innovations 
in the medical field and dealing with policy and 
accreditation issues.  Institutions involved in stem 
cell research should be properly accredited and their 
research results verified. Vigilance should be 
exercised by the medical department on the 
haphazard commercialization of this avenue.  
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Tables 
TABLE 1 SOCIO-DEMOGRAPHIC CHARACTERISTICS OF HEALTH PROFESSIONALS INTERVIEWED (N=200). 
 
Figures 
FIGURE 1 PERCENTAGE OF AFIRMATIVE 
RESPONSES ON KEY ETHICAL CONSIDERATIONS 
AMONG HEALTH PROFESSIONALS. 
 
FIGURE 2 CONCERNS ABOUT STEM CELL 
RESEARCH AMONG HEALTH PROFESSIONALS 
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Characteristic Category              Number(n)      %      
Age <45 yrs 126 63 
 >45yrs 54 27 
Gender Male 142 71 
 Female 58 29 
Education MBBS 48 24 
 MD 130 66 
 PhD 6 3 
 Others 12 7 
Grade Demonstrator 86 44 
 Assistant Professor 12 7 
 Associate Professor 36 19 
 Reader 46 23 
 Professor 14 7 
Specializations Medical  78 39 
 Surgical  60 30 
 Dental 6 3 
 Pre/para Medical 44 22 
 Public health 16 8 
